Guryanova, Olga A <br/><br/>
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.  [electronic resource] 

 -  Nature medicine  12 2016 
 - 1488-1495 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/nm.4210  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Cell Line, Tumor<br/>Cell Proliferation--genetics<br/>Cell Survival<br/>Chromatin Assembly and Disassembly--genetics<br/>DNA (Cytosine-5-)-Methyltransferases--genetics<br/>DNA Methyltransferase 3A<br/>Daunorubicin--therapeutic use<br/>Drug Resistance, Neoplasm--genetics<br/>Hematopoietic Stem Cells<br/>Humans<br/>Immunoblotting<br/>Immunoprecipitation<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mass Spectrometry<br/>Mice<br/>Mutation<br/>Nuclear Proteins--genetics<br/>Nucleophosmin<br/>Nucleosomes--metabolism<br/>fms-Like Tyrosine Kinase 3--genetics